[Autoimmune thrombocytopenic purpura preceding Hodgkin lymphoma].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000276:immunology; D001761:Bleomycin / Q000627:therapeutic use; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007132:Immunoglobulin Isotypes / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011696:Purpura, Thrombocytopenic / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014747:Vinblastine; D014750:Vincristine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D007132:Immunoglobulin Isotypes; D001761:Bleomycin; D011344:Procarbazine; D014750:Vincristine; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone